Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan and Melphalan Conditioning for Multiple Myeloma ASCT
NCT01923935Phase 2Unknown
- Sponsor
- Chonnam National University Hospital
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, melphalan in multiple myeloma (MM), sponsored by Chonnam National University Hospital. Status: unknown.
02
Drugs
busulfanmelphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01923935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923935.